Sensitive ASX Announcement

FDA allows Clinuvel's innovative vitiligo trial

Published: 03/03/11, 08:27am (AEST)3 pages
Clinuvel Pharmaceuticals Limited
CUV:ASXHealthcare

Recent CUV Announcements

Price Sensitive only